An organization that promotes exports stated that a new law that centralizes the licensing procedure for medicine exports through a web portal might reduce shipments by over 45%, asking for time to transition to the new system.
Indian small pharma firms are struggling with the complex requirements of the new Schedule M rules, with December 31, 2025, looming near. Harish K Jain, director at Embiotic Labs and president of the Federation of Pharmaceutical Entrepreneurs
At the CII Telangana, "Pillars of Protection" conference on pharmaceutical manufacturing safety in Hyderabad, government officials and industry professionals highlighted that safety needs to be embedded in every aspect of their operations...
NITI Aayog requested across-the-board quality makeover of India's pharma industry, while top industry bodies rang alarm bells on systemic issues that are stifling compliance with international standards.
Building on recent efforts to enhance healthcare and pharmaceutical cooperation, India and Uzbekistan are eager to explore new areas of collaboration following a virtual session.
.jpeg)
Drugs Consultative Committee (DCC) has sanctioned the modification of the Drugs Rules, 1945, so that products derived from stem cells and gene therapy products can be encompassed in securing a manufacturing license.
.jpeg){kind=spacer}
Janssen-Cilag International NV, which is a Johnson & Johnson subsidiary, submitted an extension of indication application to the European Medicines Agency (EMA) for the approval of AKEEGA
In the most significant move towards the standardization of language across the Indian healthcare system, the National Commission for Allied and Healthcare Professions (NCAHP) set up by the Union Health Ministry
In one of India’s deadliest industrial disasters in recent years, the death toll from the massive explosion at Sigachi Industries’ pharmaceutical manufacturing unit in Telangana has risen to 36. The blast occurred in the spray-dryer section of...
Indian generic drug firms are reconsidering their US export strategy after US President Donald Trump issued an executive order (EO) to cut prescription drug prices.
, CDSCO.jpg)
